Medtronic (MDT) Research & Development (2016 - 2026)
Medtronic (MDT) has disclosed Research & Development for 13 consecutive years, with $722.0 million as the latest value for Q1 2026.
- Quarterly Research & Development rose 6.96% to $722.0 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $2.9 billion through Jan 2026, up 5.99% year-over-year, with the annual reading at $2.7 billion for FY2025, 0.11% changed from the prior year.
- Research & Development hit $722.0 million in Q1 2026 for Medtronic, down from $754.0 million in the prior quarter.
- In the past five years, Research & Development ranged from a high of $754.0 million in Q4 2025 to a low of $641.0 million in Q2 2023.
- Historically, Research & Development has averaged $687.5 million across 5 years, with a median of $684.0 million in 2025.
- Biggest YoY gain for Research & Development was 11.15% in 2022; the steepest drop was 7.73% in 2022.
- Year by year, Research & Development stood at $676.0 million in 2022, then increased by 3.25% to $698.0 million in 2023, then dropped by 0.14% to $697.0 million in 2024, then grew by 8.18% to $754.0 million in 2025, then dropped by 4.24% to $722.0 million in 2026.
- Business Quant data shows Research & Development for MDT at $722.0 million in Q1 2026, $754.0 million in Q4 2025, and $726.0 million in Q3 2025.